KLK3 and metastatic prostate carcinoma: Based on this finding and supporting literature, clinicians should remain vigilant for metastatic prostate cancer in older men presenting with unexplained pleural effusions—even in the absence of classic risk factors—since advanced or high-grade disease may secrete minimal PSA.